Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Artur Świerczek"'
Autor:
Artur Świerczek, William J. Jusko
Publikováno v:
Clinical and Translational Science, Vol 16, Iss 9, Pp 1667-1679 (2023)
Abstract Dexamethasone (DEX) given at a dose of 6 mg once‐daily for 10 days is a recommended dosing regimen in patients with coronavirus disease 2019 (COVID‐19) requiring oxygen therapy. We developed a population pharmacokinetic and pharmacodynam
Externí odkaz:
https://doaj.org/article/57011fa882704e808777f2b7866cdef9
Autor:
Szczepan Mogilski, Monika Kubacka, Artur Świerczek, Elżbieta Wyska, Katarzyna Szczepańska, Jacek Sapa, Katarzyna Kieć-Kononowicz, Dorota Łażewska
Publikováno v:
Pharmaceuticals, Vol 16, Iss 10, p 1481 (2023)
Itch and pain are closely related but distinct sensations that share largely overlapping mediators and receptors. We hypothesized that the novel, multi-target compound E153 has the potential to attenuate pain and pruritus of different origins. After
Externí odkaz:
https://doaj.org/article/6cd04dd7b53146d69e2538b00099cbd6
Autor:
Monika Kubacka, Szczepan Mogilski, Marek Bednarski, Krzysztof Pociecha, Artur Świerczek, Noemi Nicosia, Jakub Schabikowski, Michał Załuski, Grażyna Chłoń-Rzepa, Jörg Hockemeyer, Christa E. Müller, Katarzyna Kieć-Kononowicz, Magdalena Kotańska
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 17, p 13378 (2023)
The platelet aggregation inhibitory activity of selected xanthine-based adenosine A2A and A2B receptor antagonists was investigated, and attempts were made to explain the observed effects. The selective A2B receptor antagonist PSB-603 and the A2A rec
Externí odkaz:
https://doaj.org/article/d94c1a85df5b41e7b86ef80032e07939
Autor:
Artur Świerczek, Krzysztof Pociecha, Hanna Plutecka, Marietta Ślusarczyk, Grażyna Chłoń-Rzepa, Elżbieta Wyska
Publikováno v:
Pharmaceutics, Vol 14, Iss 5, p 1090 (2022)
Current treatment strategies of autoimmune diseases (ADs) display a limited efficacy and cause numerous adverse effects. Phosphodiesterase (PDE)4 and PDE7 inhibitors have been studied recently as a potential treatment of a variety of ADs. In this stu
Externí odkaz:
https://doaj.org/article/6229171f68fc4b698ffb605466b18254
Publikováno v:
Pharmaceutics, Vol 13, Iss 5, p 597 (2021)
This study aimed to assess the efficacy and explore the mechanisms of action of a potent phosphodiesterase (PDE)7A and a moderate PDE4B inhibitor GRMS-55 in a mouse model of autoimmune hepatitis (AIH). The concentrations of GRMS-55 and relevant bioma
Externí odkaz:
https://doaj.org/article/609c476067c8494e8b794168fc7ec429
Autor:
Katarzyna Wójcik-Pszczoła, Grażyna Chłoń-Rzepa, Agnieszka Jankowska, Marietta Ślusarczyk, Paweł E Ferdek, Agnieszka A Kusiak, Artur Świerczek, Krzysztof Pociecha, Paulina Koczurkiewicz-Adamczyk, Elżbieta Wyska, Elżbieta Pękala, Reinoud Gosens
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 11, p 4008 (2020)
Phosphodiesterase (PDE) inhibitors are currently a widespread and extensively studied group of anti-inflammatory and anti-fibrotic compounds which may find use in the treatment of numerous lung diseases, including asthma and chronic obstructive pulmo
Externí odkaz:
https://doaj.org/article/160028881e804d4c89fcd52f68c5cf96
Autor:
Natalia Szozda, Artur Świerczek
Publikováno v:
Electronic Markets. 32:873-898
Publikováno v:
Gospodarka Materiałowa i Logistyka. :2-11
Autor:
Uniwersytet Ekonomiczny w Katowicach, Uniwersytet Ekonomiczny we Wrocławiu, Natalia Szozda, Artur Świerczek
Publikováno v:
Gospodarka Materiałowa i Logistyka. 2021:2-12